Key facts
- Shape Memory Medical’s last known valuation is $93.0M (Dec 2024).
- It has raised $58.0M across 5 recorded rounds; the latest was Early Stage VC ($17.0M) in Apr 2025.
- Notable investors include MedTech Innovator, Earlybird Venture Capital, HBM Partners, Emergent Medical Partners, HBM Healthcare Investments — 10 tracked in total.
- Shape Memory Medical has filed 7 Form Ds with the SEC since 2017, most recently Oct 2025 ($4.4M sold to 29 investors).
- Status: Privately Held (backing).
- ·Post-money valuations for all 5 rounds
- ·The complete investor list — 10 names
- ·Watchlist + deal alerts for Shape Memory Medical
Funding rounds
5 roundsAbout Shape Memory Medical
Developer of a medical device designed to cater to the peripheral vascular, cardiovascular and neurovascular markets. The company's devices are dedicated to developing innovative therapeutic services and utilizing shape memory polymer technology in the vascular market, enabling physicians to improve patient care.
- Sector
- Healthcare
- HQ
- San Jose, CA, United States
- Founded
- 2009
- Employees
- 47
- Website
- shapemem.com/
- Ownership
- Privately Held (backing)
Shape Memory Medical doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Shape Memory Medical shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Shape Memory Medical in its N-PORT filings yet. We sweep new filings monthly.